Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026
Rhea-AI Summary
Cryoport (Nasdaq: CYRX) will report first quarter 2026 financial results after U.S. markets close on Monday, May 4, 2026. A "Cryoport First Quarter 2026 in Review" document will be released at 4:05 p.m. ET, followed by a Q&A conference call at 5:00 p.m. ET.
A slide deck will accompany the call; a live webcast and dial-in details are available on the company's Investor Relations site, and replays will be posted and available by phone through May 11, 2026.
Positive
- None.
Negative
- None.
News Market Reaction – CYRX
In the Apr 21 session, CYRX gained 0.85%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 17 | Earnings date notice | Neutral | +1.4% | Set date and format for Q4 and full-year 2025 financial results call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings date news for CYRX was followed by a modest positive move of 1.44%, indicating a history of mild constructive reactions to scheduling announcements.
Over recent months, Cryoport has combined steady financial progress with consistent communication around results. The prior earnings date announcement on Feb 17, 2026 preceded the Q4/FY2025 release and coincided with a 1.44% gain, while full results on Mar 3, 2026 showed FY2025 revenue of $176.2M, 12% growth and guidance of $190.0M–$194.0M for 2026. Today’s Q1 2026 timing update fits that established cadence of pre-release disclosures and structured Q&A calls.
AI-generated analysis. How Rhea-AI works. Not financial advice.
In addition to the earnings release, a document titled "Cryoport First Quarter 2026 in Review", providing a review of Cryoport's financial and operational performance and a general business update, will be issued at 4:05 p.m. ET on Monday, May 4, 2026. The document is designed to be read in advance of the questions and answers conference call and will be accessible at https://ir.cryoportinc.com/news-events/ir-calendar.
Cryoport management will host a conference call the same day at 5:00 p.m. ET. The conference call will be in the format of a questions and answers session and will address questions members of the investment community have regarding the Company's reported results. A slide deck will accompany the call.
Conference Call Information | |
Date: Time: | Monday, May 4, 2026 5:00 p.m. ET |
Dial-in numbers: | 1-800-717-1738 ( |
Confirmation code: | Request the "Cryoport Call" or Conference ID: 1191652 |
Live webcast: | 'Investor Relations' section at www.cryoportinc.com or click here. |
Please allow 10 minutes prior to the call to visit this site to download and install any necessary audio software.
The questions and answers call will be recorded and available approximately three hours after completion of the live event in the Investor Relations section of the Company's website at www.cryoportinc.com for a limited time. To access the replay of the questions and answers click here. A dial-in replay of the call will also be available to those interested, until May 11, 2026. To access the replay, dial 1-844-512-2921 (
About Cryoport, Inc
Cryoport, Inc. (Nasdaq: CYRX), is a leading global provider of integrated, temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine. We support biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products designed to minimize risk and maximize reliability across the temperature-controlled supply chain for the life sciences. Our integrated supply chain platform includes the Cryoportal® Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, cryopreservation services, and cryogenic systems, which in varying combinations deliver end-to-end solutions that meet the rigorous demands of the life sciences. With innovation, regulatory compliance, and agility at our core, we are "Enabling the Future of Medicine™."
Headquartered in
For more information, visit www.cryoportinc.com or follow via LinkedIn at https://www.linkedin.com/company/cryoportinc or @cryoport on X at www.x.com/cryoport for live updates.
Forward-Looking Statements
Statements in this press release which are not purely historical, including statements regarding Cryoport's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that Cryoport's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic and geopolitical conditions, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, trends in the products markets, variations in Cryoport's cash flow, market acceptance risks, and technical development risks. Cryoport's business could be affected by other factors discussed in Cryoport's SEC reports, including in the "Risk Factors" section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and Cryoport cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, Cryoport disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cryoport-to-report-first-quarter-2026-financial-results-on-may-4-2026-302747651.html
SOURCE Cryoport, Inc.